Top news of January: Dupilumab for eosinophilic esophagitis, cell phone allergy, more
Click Here to Manage Email Alerts
Healio compiled the most-read news in allergy, asthma and immunology posted in January.
Highlights included an FDA approval for eosinophilic esophagitis, allergic contact dermatitis caused by a cell phone screen protector, the role of household disinfectants in asthma, what the loss of Flovent means for asthma patients, and more.
FDA approves dupilumab for children with eosinophilic esophagitis
The FDA has approved the use of dupilumab (Dupixent; Regeneron, Sanofi) for treating eosinophilic esophagitis in children aged 1 to 11 years who weigh at least 15 kg. Also, Marc E. Rothenberg, MD, PhD, provides his Perspective. Read more.
Cell phone screen protector triggers allergic contact dermatitis
During a presentation at the American College of Allergy, Asthma & Immunology (ACAAI) Annual Scientific Meeting, Mohammad A. Younus, MD, described how sensitivity to ethyl acrylate and other plastics in a cell phone screen protector caused itching, erythema and vesicles on a woman’s face, ear and neck. Read more.
Household disinfectants, cleaning products associated with uncontrolled asthma
Uncontrolled asthma was associated with weekly use of household disinfectants and cleaning products, including sprays and wipes, in a study published in The Journal of Allergy and Clinical Immunology: In Practice. Read more.
Q&A: Asthma patients have options as GSK moves Flovent to generic production
In the wake of the pharmaceutical company’s shift in manufacturing, Angela Duff Hogan, MD, FAAAAI, FACAAI, FAAP, of the ACAAI Asthma Committee, reviews the alternatives that physicians and patients can employ to maintain their care. Read more.
Peanut introduction largely successful among cohort of high-risk infants
Researchers found low rates of new peanut allergy and generally low rates of peanut discontinuation after introduction in a cohort of high-risk infants, Corinne Keet, MD, PhD, of University of North Carolina, Chapel Hill, told Healio. Read more.
Insect venom causes most occupational anaphylaxis
Insect venom was the cause of most cases of occupational anaphylaxis, followed by food, drugs and latex, Margitta Worm, MD, of University Hospital Charité, told Healio. Also, John J. Oppenheimer, MD, shares his Perspective. Read more.
Success limited in oral immunotherapy for adults with food allergies
About half of a cohort of adults with food allergies stopped treatment within 2 years, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice. Also, Scott H. Sicherer, MD, FAAP, shares his Perspective. Read more.
Q&A: Fundraising campaign scores $1 million for food allergy research, education
Food Allergy Research & Education’s 2023 fundraising campaign included $100,000 in matched donations from Brittany Mahomes and her partners at OWYN. Craig Fontenot, MBA, vice president of institutional advancement at the nonprofit, provides the details. Read more.
Oncologists satisfied with e-consults after chemotherapy reactions
An e-consult program for oncologists and allergy specialists at Massachusetts General Hospital had a mean turnaround time of 19.7 hours, Aleena Banerji, MD, and Kimberly G. Blumenthal, MD, MSC, told Healio. Also, Cosby A. Stone Jr., MD, MPH, and Afreen Shariff, MD, MBBS, share their Perspectives. Read more.
Some children avoid peanuts despite negative oral food challenges
Reasons for avoiding peanut included parent-reported peanut allergies and family histories of food allergy, Omega Wai-Yan Leong, BMedSci, MBBS(Hons), FRACP, and Rachel L. Peters, PhD, told Healio. Also, Aikaterini (Katherine) Anagnostou, MD(Hons), MSc, PhD, and Sandra J. Hong, MD, offer their Perspectives. Read more.